Pediatrix Medical Group, Inc. (NYSE:MD) Receives $21.00 Consensus PT from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have earned an average rating of “Hold” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $21.00.

Several research firms recently issued reports on MD. Zacks Research lowered Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Friday, January 23rd. Weiss Ratings reiterated a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Monday, December 29th. Truist Financial raised their target price on shares of Pediatrix Medical Group from $17.00 to $24.00 and gave the company a “hold” rating in a research note on Monday, November 10th. Finally, UBS Group boosted their target price on shares of Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a report on Wednesday, November 5th.

Insider Transactions at Pediatrix Medical Group

In other Pediatrix Medical Group news, CEO Mark S. Ordan sold 23,000 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $22.41, for a total value of $515,430.00. Following the sale, the chief executive officer owned 302,805 shares in the company, valued at $6,785,860.05. This represents a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Michael A. Rucker sold 10,478 shares of Pediatrix Medical Group stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $23.00, for a total value of $240,994.00. Following the transaction, the director owned 59,101 shares of the company’s stock, valued at $1,359,323. This represents a 15.06% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Pediatrix Medical Group

A number of institutional investors have recently made changes to their positions in the company. Global Retirement Partners LLC increased its position in Pediatrix Medical Group by 68,250.0% during the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after buying an additional 1,365 shares during the period. Eurizon Capital SGR S.p.A. bought a new position in Pediatrix Medical Group during the fourth quarter worth about $33,000. Blue Trust Inc. acquired a new stake in Pediatrix Medical Group in the 4th quarter worth about $37,000. TD Private Client Wealth LLC acquired a new stake in Pediatrix Medical Group in the 4th quarter worth about $39,000. Finally, Los Angeles Capital Management LLC bought a new stake in Pediatrix Medical Group in the 4th quarter valued at about $43,000. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Down 1.8%

Shares of MD stock traded down $0.39 during trading on Thursday, reaching $21.08. The company’s stock had a trading volume of 32,598 shares, compared to its average volume of 526,436. Pediatrix Medical Group has a one year low of $11.84 and a one year high of $24.99. The business has a fifty day moving average price of $21.72 and a 200-day moving average price of $19.19. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 11.20 and a beta of 0.76. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.65.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.